Daily Archives: 3 February 2021

Biophytis Announces the Start of Patient Recruitment in Brazil and the USA for Part 2 of the Phase 2-3 COVA Trial (“COVA Study”)

Biophytis Announces the Launch of its Proposed Public Offering and Nasdaq Listing